[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100337298":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":56,"collaborators":18,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":18,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":18,"enrollmentInfo":69,"targetDuration":18,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":40,"whyStopped":18,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Umeå University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention group","EXPERIMENTAL","In addition to a standard medication review at the hospital, this group also receives an enhanced clinical pharmacist service during 180 days after discharge from the hospital.",[13],"Other: Enhanced clinical pharmacist service",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","This group receives standard care, which might include a medication review at the hospital.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Enhanced clinical pharmacist service","The intervention includes regular medical chart reviews, multiple patient interviews and, if needed, collaboration with the primary care physician.",[9],[25],{"name":26,"affiliation":5,"role":27},"Maria Gustafsson, Ph.D","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":18,"email":33},"Kindstedt","CONTACT","+46706572422","jonas.kindstedt@umu.se",{"name":26,"role":31,"phone":35,"phoneExt":18,"email":36},"+46907853562","maria.gustafsson@umu.se",[38],{"facility":39,"status":40,"city":41,"state":18,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Medical Centre, University Hospital of Umeå","RECRUITING","Umeå","901 85","Sweden","SE",{"type":46,"coordinates":47},"Point",[48,49],20.25972,63.82842,{"lat":49,"lon":48},[52],{"name":53,"role":31,"phone":54,"phoneExt":18,"email":55},"Matsson","+4690-785 84 02","cecilia.mattsson@vll.se",{"type":27,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Maria Gustafsson","Principal Investigator","100337298","clinical-pharmacist-intervention-to-reduce-drug-related-readmissions-among-older-people-100337298",false,"NCT03671629","Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People","Involving Clinical Pharmacists in Transitional Care to Reduce Drug-related Readmissions Among the Elderly - a Randomized Controlled Trial","Inclusion Criteria:\n\n* Living at home\n* Acutely admitted\n* Registered at one of ten pre-specified primary care health centers\n\nExclusion Criteria:\n\n* Patients unable to communicate or who do not speak Swedish\n* Patients scheduled for palliative care\n* Patients admitted due to intoxication by alcohol or drug (non prescription)",true,"ALL","75 Years",{"count":70,"type":71},700,"ESTIMATED","INTERVENTIONAL",[74],"NA","This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients \\>75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.",[77],"Drug Use",[79,80,81,82],"Clinical pharmacist","Elderly","Adherence","Drug-related readmission","2024-12-17",{"date":85,"type":86},"2024-12-20","ACTUAL",{"date":88,"type":86},"2018-09-19",{"date":90,"type":71},"2026-12",{"name":5,"class":6},1]